Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash provided by (used for) operating activities
Net income (loss)	$ 1,467	$ 815
Depreciation and amortization	661	615
Deferred and prepaid income taxes	(49)	21
Stock-based compensation expense	149	129
Goodwill and other intangible asset impairment charges	46	276
Net loss (gain) on investments and notes receivable	(191)	46
Contingent consideration net expense (benefit)	0	18
Inventory step-up amortization	118	0
Other, net	72	8
Trade accounts receivable	(139)	(228)
Inventories	(44)	(219)
Other assets	(108)	(126)
Accounts payable, accrued expenses and other liabilities	(154)	(379)
Cash provided by (used for) operating activities	1,827	977
Investing activities:
Purchases of property, plant and equipment and internal use software	(344)	(334)
Payments for acquisitions of businesses, net of cash acquired	(1,248)	(95)
Payments for investments and acquisitions of certain technologies	(110)	(139)
Proceeds for settlements of hedge contracts	69	0
Other, net	7	12
Cash provided by (used for) investing activities	(1,626)	(556)
Financing activities:
Payment of contingent consideration previously established in purchase accounting	(62)	(34)
Payments for finance leases	(42)	(25)
Payments on short-term borrowings	(1,583)	(504)
Proceeds from long-term borrowings, net of debt issuance costs	1,558	2,145
Cash used to net share settle employee equity awards	(123)	(80)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans	147	106
Other, net	(1)	(15)
Cash provided by (used for) financing activities	(107)	1,593
Effect of foreign exchange rates on cash	41	(8)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	135	2,006
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	606	1,055
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	741	3,062
Supplemental Information
Stock-based compensation expense	149	129
Cash and cash equivalents	534	2,913
Restricted cash and restricted cash equivalents included in Other current assets	109	75
Restricted cash equivalents included in Other long-term assets	98	74
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 741	$ 3,062